Clinical Trials Logo

Clinical Trial Summary

The study hypothesis is that the use of running epidermal sutures in full-thickness skin graft (FTSG) placement for patients undergoing dermatologic surgery (Mohs micrographic surgery or excision) is non-inferior to the use of simple interrupted sutures with respect to cosmetic outcome. This will be a split-scar (within-person) study, in which half of each participant's scar will receive the study intervention (running epidermal sutures), with the other half receiving the control intervention (simple interrupted sutures). The primary outcome, total observer score of the Patient and Observer Scar Assessment Scale (POSAS) 2.0, will be assessed by two blinded observers at a 3-month follow-up visit, and compared between scar halves.


Clinical Trial Description

A FTSG is used in lieu of linear repair or local tissue skin flap rearrangement when surrounding skin tissue laxity is unavailable or the patient prefers a graft instead. Typically the skin for a FTSG is harvested from a local or distant donor site depending on skin tissue match and tissue availability and sutured into place. The site where the FTSG was taken is primarily repaired or allowed to heal via second intent. This study is important because it provides a comparison of cosmetic outcome between interrupted versus running cutaneous sutures. The information provided would help determine if a more efficient suturing technique is non-inferior to a less efficient one, thus saving time for the patient and provider. There is no current standard of practice, with dermatologic surgeons using both interrupted and running sutures, as there is a paucity of literature on this topic as related to full thickness grafts after dermatologic surgery. Running epidermal sutures are more time efficient and thus decrease patient intra-operative time, save on suture material, increase surgeon productivity, and may improve the overall patient operative experience. There have been multiple other split scar studies and studies related to the cosmetic outcomes of various suturing practices. However, there have been none that have looked at simple versus running epidermal stitching of FTSG placement. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06233812
Study type Interventional
Source Northwell Health
Contact Marcus L Elias, MD
Phone 862-371-6427
Email melias2@northwell.edu
Status Recruiting
Phase N/A
Start date August 1, 2023
Completion date August 1, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04997863 - Clinical Efficacy and Safety of Sericin Hydrogel Sheet Impregnated With Bird's Nest Extract N/A
Completed NCT05335720 - Efficacy and Safety Evaluation of EASYEF® in Acute Wound (Split-thickness Skin Graft Donor Site) N/A
Active, not recruiting NCT04456127 - CO2 Laser Revision for Burn Related Donor Site Scars N/A
Recruiting NCT05447793 - Effectiveness and Tolerability of Fitostimoline Plus vs Connettivina Bio Plus in Skin Graft
Recruiting NCT04186273 - Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2. Phase 2
Completed NCT04176705 - Fractional Ablative Laser Treatment for Skin Grafts N/A
Completed NCT06044519 - A Single Center Trial of Donor Site Wound Dressings After Split Thickness Skin Grafting. Phase 4